NCT07303543

Brief Summary

The aim of this clinical trial is to investigate the effectiveness of collagen, considered a new approach to prevent muscle mass loss after bariatric surgery, and to demonstrate the relationship between this effect and exercise. The key questions it aims to answer are: Does whey protein supplementation with collagen combined with resistance exercise prevent muscle mass loss after bariatric surgery? Do whey protein supplementation with collagen combined with resistance exercise affect fat mass after bariatric surgery? Researchers will compare collagen with whey protein. The study groups and interventions to be implemented are summarized below: Group 1: Control Group (CG; n: 10) Whey protein supplementation will be administered Vitamin and mineral supplementation will be administered No resistance exercise will be performed The participants will eat according to bariatric surgery nutrition guidelines and perform physical activities. Group 2: Whey Protein + Collagen + Exercise Group (WPCEG; n: 10) Whey protein supplements with collagen will be given. Vitamin and mineral supplements will be given. Resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities. They will begin a resistance exercise program 4 weeks after surgery. Group 3: Whey Protein + Collagen + No Exercise Group (WPCG; n: 10) Whey protein supplements with collagen will be given. Vitamin and mineral supplements will be given. No resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities. Group 4: Whey Protein + Exercise Group (WPEG; n: 10) Whey protein supplements will be given. Vitamin and mineral supplements will be given. Resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities. A resistance exercise program will begin at 4 weeks post-operatively.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2022

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 26, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

3.4 years

First QC Date

November 17, 2025

Last Update Submit

December 10, 2025

Conditions

Keywords

Bariatric SurgeryCollagenResistance exerciseWhey proteinMuscle loss

Outcome Measures

Primary Outcomes (1)

  • Change in Skeletal Muscle Mass (kg) Measured by BIA

    Skeletal muscle mass (kg) will be measured using a multi-frequency bioelectrical impedance analysis (BIA) device. The outcome will be reported as the mean change from baseline at each time point in each study group.

    Baseline (preoperative), postoperative week 4 (day 29), and postoperative week 12 (day 85)

Secondary Outcomes (1)

  • Change in Fat Mass (kg) Measured by BIA

    Baseline, week 4, and week 12

Study Arms (4)

Control Group (CG)

ACTIVE COMPARATOR

Whey protein supplementation will be provided. Vitamin and mineral supplementation will be administered. No resistance exercise will be performed. Participants will follow bariatric surgery nutrition guidelines and maintain their regular physical activities. A comparison will be made with the other groups as the control group.

Dietary Supplement: Whey protein supplementDietary Supplement: Vitamin and Mineral Supplementation

Whey Protein + Collagen + Exercise Group (WPCEG)

EXPERIMENTAL

Collagen-containing whey protein supplementation will be provided. Vitamin and mineral supplementation will be given. Resistance exercises will be performed. Participants will follow bariatric surgery nutrition guidelines and maintain their physical activities. They will begin the resistance exercise program in the 4th week after surgery.

Dietary Supplement: Whey protein supplementDietary Supplement: Hydrolyzed Collagen SupplementDietary Supplement: Vitamin and Mineral SupplementationBehavioral: Resistance Exercise Program

Whey Protein + Collagen + Non-Exercise Group (WPCG)

EXPERIMENTAL

Collagen-containing whey protein supplementation will be provided. Vitamin and mineral supplementation will be administered. No resistance exercises will be performed. Participants will follow bariatric surgery nutrition guidelines and maintain their physical activities.

Dietary Supplement: Whey protein supplementDietary Supplement: Vitamin and Mineral Supplementation

Whey Protein + Exercise Group (WPEG)

EXPERIMENTAL

Whey protein supplementation will be provided. Vitamin and mineral supplementation will be given. Resistance exercises will be performed. Participants will follow bariatric surgery nutrition guidelines and maintain their physical activities. They will begin the resistance exercise program in the 4th week after surgery.

Dietary Supplement: Whey protein supplementDietary Supplement: Vitamin and Mineral SupplementationBehavioral: Resistance Exercise Program

Interventions

Whey protein supplementDIETARY_SUPPLEMENT

Oral whey protein supplement provided daily according to bariatric surgery nutrition protocol.

Control Group (CG)Whey Protein + Collagen + Exercise Group (WPCEG)Whey Protein + Collagen + Non-Exercise Group (WPCG)Whey Protein + Exercise Group (WPEG)

Oral hydrolyzed collagen supplement provided daily in combination with whey protein.

Whey Protein + Collagen + Exercise Group (WPCEG)

Routine vitamin and mineral supplementation according to bariatric surgery follow-up protocol.

Control Group (CG)Whey Protein + Collagen + Exercise Group (WPCEG)Whey Protein + Collagen + Non-Exercise Group (WPCG)Whey Protein + Exercise Group (WPEG)

Structured resistance exercise program initiated at postoperative week 4, supervised, 3 times per week.

Whey Protein + Collagen + Exercise Group (WPCEG)Whey Protein + Exercise Group (WPEG)

Eligibility Criteria

Age20 Years - 50 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsman and woman
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being between 20-50 years old
  • Body mass index; 35 ≤ BMI\< 60 kg/m2
  • Not being pregnant
  • Not being addicted to alcohol and drugs
  • Not having entered menopause
  • No exercise restrictions

You may not qualify if:

  • Having at least one of the following inflammatory bowel diseases, upper gastrointestinal bleeding, advanced psychiatric diseases, cancer, and kidney failure.
  • using statins
  • be pregnant
  • Being addicted to alcohol and drugs
  • to have entered menopause
  • Having exercise restrictions
  • Becoming a professional athlete
  • Having done more than 60 minutes of regular and structured exercise per week in the last year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University

Istanbul, Fatih, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Muscular Atrophy

Interventions

Vitamins

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

MicronutrientsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesNutrientsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Halit E Taşkın, Dr.

    Cerrahpaşa Faculty of Medicine, General Surgery

    PRINCIPAL INVESTIGATOR
  • Nihal Z Erdem, PhD

    Istanbul Medipol University, Nutrition and Dietetics

    PRINCIPAL INVESTIGATOR
  • Bürke Köksalan, PhD

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rüken A Samancı, Msc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

November 17, 2025

First Posted

December 26, 2025

Study Start

August 2, 2022

Primary Completion

December 20, 2025

Study Completion

January 30, 2026

Last Updated

December 26, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because this study involves identifiable clinical and nutritional data collected at a single center, and participant privacy cannot be fully ensured despite anonymization

Locations